Intravitreal Bevacizumab for the Treatment of Chronic or Recurrent Central Serous Chorioretinopathy

Abstract

Background: We report the use of intravitreal bevacizumab as an option for the treatment of chronic or recurrent central serous chorioretinopathy (CSC). Methods: Eight eyes with chronic or recurrent CSC received intravitreal bevacizumab (1.25 mg/0.05 cc) and underwent best corrected visual acuity (VA), optical coherent tomography (OCT), fluorescein angiography (FA) and indocyanine green angiography (ICG) before, and one, three and six months after treatment. Results: All patients showed improvement in visual acuity, fluorescein angiographic leakage, choroidal hyperpermeability and reduced or resolved neurosensory detachment following treatment. Two patients require a second dose of intravitreal bevacizumab. Conclusions: Intravitreal injection of bevacizumab was associated with visual improvement and reduced neurosensory detachment without adverse events in patients with chronic or recurrent CSC. Although these results are promising, further investigations would be helpful to understand this therapy for patients with CSC.

Share and Cite:

Torres Soriano, M.E., García Aguirre, G., Gordon Angelozzi, M., Kon Jara, V., Fromow Guerra, J., Ober, M.D. and Quiroz Mercado, H. (2014) Intravitreal Bevacizumab for the Treatment of Chronic or Recurrent Central Serous Chorioretinopathy. Open Journal of Ophthalmology, 4, 57-64. doi: 10.4236/ojoph.2014.43010.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] Ober, M.D., Yannuzzi, L.A., Do, D.V., et al. (2005) Photodynamic Therapy for Focal Retinal Pigment Epithelial Leaks Secondary to Central Serous Chorioretinopathy. Ophthalmology, 112, 2088-2094.
http://dx.doi.org/10.1016/j.ophtha.2005.06.026
[2] Yannuzzi, L.A., Slakter, J.S., Kaufman, S.R. and Gupta, K. (1992) Laser Treatment of Diffuse Retinal Pigment Epitheliopathy. European Journal of Ophthalmology, 2, 103-114.
[3] Cardillo Piccolino, F. and Borgia, L. (1994) Central Serous Chorioretinopathy and Indocyanine Green Angiography. Retina, 14, 231-242.
http://dx.doi.org/10.1016/j.ophtha.2005.06.026
[4] Guyer, D.R., Yannuzzi, L.A., Slaktler, J.S., et al. (1994) Digital Indocyanine Green Videoangiography of Central Serous Chorioretinopathy. JAMA Ophthalmology, 112, 1057-1062.
http://dx.doi.org/10.1001/archopht.1994.01090200063023
[5] Prunte, C. and Flammer, J. (1996) Choroidal Capillary and Venous Congestion in Central Serous Chorioratinopathy. American Journal of Ophthalmology, 121, 26-34.
[6] Cardillo Piccolino, F., Eandi, C.M., Ventre, L., et al. (2003) Photodynamic Therapy for Chronic Central Serous Chorioretinopathy. Retina, 23, 752-763.
http://dx.doi.org/10.1097/00006982-200312000-00002
[7] Chan, W.M., Lam, D.S., Lai, T.Y., et al. (2003) Choroidal Vascular Remodeling in Central Serous Chorioretinopathy after Indocyanine Green Guided Photodynamic Therapy with Verteporfin: A Novel Treatment at the Primary Disease Level. British Journal of Ophthalmology, 87, 1453-1458.
http://dx.doi.org/10.1136/bjo.87.12.1453
[8] Colucciello, M. (2006) Choroidal Neovascularization Complication Photodynamic Therapy for Central Serous Retinopathy. Retina, 26, 239-242.
http://dx.doi.org/10.1097/00006982-200602000-00027
[9] Bujarborua, D. and Nagpal P. (2005) CSR: Idiopathic Central Serous Chorioretinopathy. Jaypee Brothers Medical Publishers, New Delhi.
[10] Leaver, P. and Willians, C. (1979) Argon Laser Photocoagulation in the Treatment of Central Serous Retinopathy. British Journal of Ophthalmology, 63, 674-677.
http://dx.doi.org/10.1136/bjo.63.10.674
[11] Flicker, L., Vadifis, G., While, A. and Leaver, P. (1988) Long Term Follow up of a Prospective Trial of Argon Laser Photocoagulation in the Treatment of Central Serous Retinopathy. British Journal of Ophthalmology, 72, 829-834.
http://dx.doi.org/10.1136/bjo.72.11.829
[12] Yannuzzi, L.A., Shakin, J.L., Fisher, Y.L. and Altomonte, M. (1984) Peripheral Detachments and Retinal Pigment Epithelial Atrophic Tracts Secondary to Central Serous Pigment Epitheliopathy. Ophthalmology, 91, 1553-1572.
http://dx.doi.org/10.1016/S0161-6420(84)34117-3
[13] Jalk, A.E., Jabbour, N., Avila, M., Trempe, C.L. and Schepens, C.l. (1984) Retinal Pigment Epithelium Decompesation. II. Laser Treatment. Ophthalmology, 91, 1549-1553.
http://dx.doi.org/10.1016/S0161-6420(84)34118-5
[14] Yannuzzi, L.A. (1989) Central Serous Chorioratinopathy. In: Yannuzzi, L.A., Ed., Laser Photocoagulation of the Macula, Lippincott, Philadelphia, 1-12.
[15] Battaglia Parodi, M., Da Pozzo, S. and Ravalico, G. (2003) Photodynamic Therapy in Chronic Central Seroschorioretinopathy. Retina, 23, 235-237.
http://dx.doi.org/10.1097/00006982-200304000-00016
[16] Cardillo Piccolino, F., Eandi, C.M., Ventre, L., et al. (2003) Photodynamic Therapy for Chronic Central Seroschorioretinopathy. Retina, 23, 752-763.
http://dx.doi.org/10.1097/00006982-200312000-00002
[17] Lai, T.Y., Chan, W.M. and Lam, D.S. (2004) Transient Reduction in Retinal Function Revealed by Multifocal Electroretinogram Following Photodynamic Therapy. American Journal of Ophthalmology, 137, 826-833.
http://dx.doi.org/10.1016/j.ajo.2003.11.079
[18] Tzekov, R., Lin, T., Zhang, K.M., et al. (2006) Ocular Changes after Photodynamic Therapy. Investigative Ophthalmology Visual Science, 47, 377-385.
http://dx.doi.org/10.1167/iovs.05-0838
[19] Oner, A., Karakucuk, S., Mirza, E. and Erkilic, K. (2005) Electrooculography after Photodynamic Therapy. Documenta Ophthalmologica, 111, 83-86.
http://dx.doi.org/10.1007/s10633-005-4410-4
[20] Oner, A., Karakucuk, S., Mirza, E. and Erkilic, K. (2005) The Changes of Pattern Electroretinography at the Early Stage of Photodynamic Therapy. Documenta Ophthalmologica, 111, 107-112.
http://dx.doi.org/10.1007/s10633-005-4608-5
[21] Verma, L., Sinha, R., Venkatesh, P. and Tewari, H.K. (2004) Comparative Evaluation of Diode Laser versus Argon laser Photocoagulation in Patients with Central Serous Retinopathy: A Pilot, Randomized Controlled Trial. BMC Ophthalmology, 4, 15.
http://dx.doi.org/10.1186/1471-2415-4-15
[22] Lim, J.I., Glassman, A.R., Aiello, L.P., et al. (2014) Collaborative Retrospective Macula Society Study of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy. Ophthalmology, 121, 1073-1078.
http://dx.doi.org/10.1016/j.ophtha.2013.11.040
[23] Niegel, M.F., Schrage, N.F., Christmann, S. and Degenring, R.F. (2008) Intravitreal Bevacizumab for Chronic Central Serous Chorioretinopathy. Ophthalmologe, 105, 943-945.
http://dx.doi.org/10.1016/j.ophtha.2013.11.040
[24] Artunay, O., Yuzbasioglu, E., Rasier, R., et al. (2010) Intravitreal Bevacizumab in Treatment of Idiopathic Persistent Central Serous Chorioretinopathy: A Prospective, Controlled Clinical Study. Current Eye Research, 35, 91-98.
http://dx.doi.org/10.3109/02713680903428306
[25] Lijima, H., Lida, T., Murayama, K., et al. (1999) Plasminogen Activator Inhibitor 1 in Central Seroschorioretinopathy. American Journal of Ophthalmology, 127, 477-478.
http://dx.doi.org/10.1016/S0002-9394(98)00378-X
[26] Shahar, J., Avery, R.L., Heilweil, G., et al. (2006) Electrophysiologic and Retinal Penetration Studies Following Intravitreal Injection of Bevacizumab (Avastin). Retina, 26, 262-269.
http://dx.doi.org/10.1097/00006982-200603000-00002
[27] Lim, J.W., Kim, M.U. and Shin, M.C. (2010) Aqueous Humor and Plasma Levels of Vascular Endothelial Growth Factor and Interleukin-8 in Patients with Central Serous Chorioretinopathy. Retina, 30, 1465-1471.
http://dx.doi.org/10.1097/IAE.0b013e3181d8e7fe
[28] Shin, M.C. and Lim, J.W. (2011) Concentration of Cytokines in the Aqueous Humor of Patients with Central Serous Chorioretinopathy. Retina, 31, 1937-1943.
http://dx.doi.org/10.1097/IAE.0b013e3181d8e7fe
[29] Semeraro, F., Romano, M.R., Danzi, P., Morescalchi, F. and Costagliola, C. (2012) Intravitreal Bevacizumab versus Low-Fluence Photodynamic Therapy for Treatment of Chronic Central Serous Chorioretinopathy. Japanese Journal of Ophthalmology, 56, 608-612.
http://dx.doi.org/10.1007/s10384-012-0162-3
[30] Bae, S.H., Heo, J., Kim, C., Kim, T.W., Shin, J.Y., Lee, J.Y., Song, S.J., Park, T.K., Moon, S.W. and Chung, H. (2014) Low-Fluence Photodynamic Therapy versus Ranibizumab for Chronic Central Serous Chorioretinopathy. Ophthalmology, 121, 558-565.
http://dx.doi.org/10.1016/j.ophtha.2013.09.024

Journals Menu
Follow SCIRP
Contact us
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.